背书
发表于 2025-3-23 10:06:50
Günther Bernatzky,Horst-Peter Hesse (†),Gunter Kreutzoclonal antibodies classified as anti-PD-1 antibodies, anti-PD-L1 antibodies, CD27 agonists, anti-B7-H3 antibodies and anti-phosphatidyl serine antibodies are discussed. Next, different cytokine-based therapies administered as recombinant proteins, plasmid electroporation or virus based transfers ar
packet
发表于 2025-3-23 14:44:07
Gerald Gattererls that tested the safety and efficacy of oncolytic viruses including T-VEC in melanoma patients are described. Then, Imlygic, the marketed formulation of T-VEC and its clinical pharmacology are discussed. The mechanism of action of T-VEC at cellular level is then explained followed by details of re
Fierce
发表于 2025-3-23 18:33:45
Dieter Schmidtditing is introduced and then the various immune evasive mechanisms employed by cancer cells are discussed including, loss of T-cell recognition caused due to loss of MHC I expression and/or loss of antigen presenting machinery, inhibition of T-cell recruitment to the tumors, intrinsic resistance to
Hangar
发表于 2025-3-23 22:20:23
http://reply.papertrans.cn/59/5833/583299/583299_14.png
相符
发表于 2025-3-24 04:19:47
Marina Kojertween the host and the tumor has been suggested. For this reason several forms of immunotherapy have been employed, resulting in a limited number of sometimes long-lasting responses . Most emphasis has been given to those forms of immunotherapy which induce stimulation of the immune-effector sys
Anticlimax
发表于 2025-3-24 09:26:24
http://reply.papertrans.cn/59/5833/583299/583299_16.png
否认
发表于 2025-3-24 13:54:16
http://reply.papertrans.cn/59/5833/583299/583299_17.png
蛙鸣声
发表于 2025-3-24 17:24:19
http://reply.papertrans.cn/59/5833/583299/583299_18.png
HALL
发表于 2025-3-24 21:26:01
Karl Cernic,Ernst J. Müller,Olivia Kadarelationship, and toxicity profile of these drugs. This chapter provides an overview of the pharmacokinetics (PK), pharmacodynamics (PD), and toxicity of the current immune checkpoint inhibitors as monotherapy and in combination. Collaborative work of basic scientists, clinical pharmacists, and onco
harrow
发表于 2025-3-25 01:34:26
http://reply.papertrans.cn/59/5833/583299/583299_20.png